Tag: Novavax

All

EU Authorizes Novavax COVID-19 Vaccine

The vaccine is now fully authorized for use as a primary series in individuals aged 12 and older and as a booster dose in adults aged 18 and older for the prevention of COVID-19.

Vaccines: Europe OK’s Novavax’s COVID-19 Vaccine Booster
Vaccines: Omicron-specific Covid Booster Shots are Arriving Soon
Coronaviruses Can Survive on Frozen Meat
FDA Authorizes Novavax COVID Vaccine
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Novavax’s COVID-19 Booster to be Evaluated in NIH Study
Canada Authorizes Novavax COVID-19 Vaccine for Adults

All

Positive Results for Novavax Vaccine in Children

Novavax Inc's COVID-19 vaccine demonstrated 80% efficacy overall in a study of over 2,000 pediatric patients when the Delta variant was the predominant circulating strain in the US.

Novavax Vaccine Authorized in Great Britain, New Zealand
Novavax Vaccine Submitted for FDA Emergency Use Authorization
Novavax Vaccine to Ship to EU in Q1
Study: Novavax Vaccine Safe and Effective
Positive Data for Coadministered Flu and COVID Vaccines
Novavax Pursuing UK Authorization for COVID-19 Vaccine

All

Novavax COVID-19 Vaccine 90% Effective Overall in Ph3 Trial

Novavax Inc's COVID-19 vaccine NVX-CoV2373 demonstrated 90.4% overall efficacy against SARS-CoV-2 infection, and 100% protection against moderate and severe disease, according to a Phase 3 PREVENT-19 clinical trial.

Novavax COVID-19 Vaccine Candidate 89.5% Effective in UK PH3 Trial
Novavax COVID-19 Vaccine Enters Ph3 Trials
Novavax Begins Phase 1/2 Study of COVID-19 Vaccine Candidate
FDA Fast Tracks NanoFlu Influenza Vaccine
NanoFlu Flu Vaccine Begins Phase 3 Trial

Tag: Novavax

All

All

All

Sorry, No Posts Found